Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • AVIA Names Daniel Clark Senior Vice President, Center for Care Transformation; Will Drive Digital Care Transformation Initiatives for Health Systems

    May 17, 2022, 15:46 PM by
    Seasoned Clinical and Digital  Executive Joins Leading Digital Transformation Company to Meet Demand for Digitally Enabled Care Models
    Full story
  • 2bPrecise Named “Best Overall Genomics Company” in 2022 MedTech Breakthrough Awards Program

    May 17, 2022, 15:46 PM by
    Full story
  • Kyruus ProviderMatchⓇ Wins MedTech Breakthrough Award for Best Patient Scheduling Solution for Third Year in Row

    May 17, 2022, 15:46 PM by
    Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies
    Full story
  • Egle Therapeutics appoints Pierre Legault as Chairman and Board Member

    May 17, 2022, 15:46 PM by
    Egle Therapeutics SAS (Egle), an emerging biotechnology company dedicated to developing novel immunotherapies for oncology and autoimmune diseases, is pleased to announce Pierre Legault as Chairman and board member as of March 2022.
    Full story
  • Paradigm4 launches REVEAL: Proteomics to transform protein bio-markers research!

    May 17, 2022, 15:46 PM by
    Paradigm4 has today unveiled REVEAL: Proteomics, the newest use case specific app powered by the Paradigm4 FLASH high-performance bioinformatics platform.
    Full story
  • Rousselot® Biomedical announces the launch of Quali-Pure HGP 2000

    May 17, 2022, 15:42 PM by
    Rousselot®, Darling Ingredients’ health brand and the global leader of collagen-based solutions1, launches Quali-Pure™ HGP 2000, a new endotoxin-controlled, pharmaceutical-grade gelatin specifically designed for vaccines and wound healing applications. As the latest addition to Rousselot Biomedical’s rapidly expanding product offering, this new non-gelling hydrolyzed gelatin further extends the scope of biomedical applications covered by Rousselot products.
    Full story
  • Watson-Marlow Fluid Technology Solutions and the National Institute for Bioprocessing Research and Training partner for biopharma training programme

    May 17, 2022, 15:42 PM by
    Watson-Marlow Fluid Technology Solutions (WMFTS) today announces it has partnered with the National Institute of Bioprocessing Research and Training (NIBRT) to develop and deliver a combined in-person and online global biopharma training programme for employees.
    Full story
  • X-Therma organ preservation technology granted FDA breakthrough device status

    May 17, 2022, 15:42 PM by
    Full story
  • PubMed Research Workflows Made Easier with PubHive Navigator

    May 17, 2022, 15:42 PM by
    New Google Chrome Browser extension simplifies research workflows for corporate life science teams that use PubMed and subscribe to PubHive’s cloud software platform
    Full story
  • ADC Technology: A Premier Institution of Antibody-Drug Conjugates Development

    May 17, 2022, 15:42 PM by
    ADC Technology releases a wide range of one-stop services related to ADC development such as antibody selection/modification, ADC payload and linker development, ADC conjugation, and ADC characterization and preclinical evaluation to help partners win the race of ADC research.
    Full story
  • Benefits of Stable Isotope Labelling in Biochemistry Research

    May 17, 2022, 15:42 PM by
    Stable isotope labeling is a powerful technique with promising applications.
    Full story
  • PROTAC-based Methods as Traditional PROTAC Protein Degradation Technology Alternatives

    May 17, 2022, 15:42 PM by
    Many emerging PROTAC-based technologies such as RNA-PROTACs and Photoswitchable PROTACs have expanded the scope of PROTAC development, providing more feasible potential strategies for the clinical treatment of related diseases.
    Full story
  • BOC Sciences Announces Featured PROTAC Design Services to Meet New Drug Discovery Goals

    May 17, 2022, 15:42 PM by
    BOC Sciences announced featured PROTAC design services to customers around the world to meet new drug discovery goals.
    Full story
  • Chemical Synthesis of Peptide Drug with Solid-Phase Methodology

    May 17, 2022, 15:42 PM by
    Peptide plays a key role in basic biochemical and physiological processes, and it is essential to many aspects of biomedical research, especially when the pharmaceutical industry continues to apply new drug candidates in the biological field. Therefore, rapid, efficient, and reliable methodology for the chemical synthesis of peptide drugs is of utmost interest in chemical biology research.
    Full story
  • Total Peptide Library: More Flexible and Productive

    May 17, 2022, 15:42 PM by
    Since the peptide library provides a powerful tool for drug development, protein-protein interactions, and other biochemical as well as pharmaceutical applications, the total peptide library becomes a productive tool as it enjoys higher stability because of the special structure of the peptide bond. Additionally, its construction cycle is relatively short compared with traditional peptide library construction technologies, accelerating the development of peptides drugs.
    Full story
  • New programme celebrates ChargePoint Technology's role in COVID-19 vaccine rollout

    May 17, 2022, 15:42 PM by
    Full story
  • New Release of Genedata Imagence Advances AI-powered HCS Image Analysis

    May 17, 2022, 15:42 PM by
    Genedata Imagence 5.0 industrializes the analysis of imaging assays across R&D organizations with advanced data QC workflows and scalable, flexible deployment options.
    Full story
  • New BHM® Anti-Viral Nasal Spray launches in Singapore

    May 17, 2022, 15:42 PM by
    Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces the Singapore launch of its latest technology, BHM® Anti-Viral Nasal Spray, an easy-to-use nasal device with a unique patented formulation, Norizite™, designed to help prevent infection from the inhalation of airborne viruses within the nasal passages. The product will be available in Singapore from 1st May.
    Full story
  • AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem

    May 17, 2022, 15:42 PM by
    AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System, and AARDEX® Group’s MEMS® Adherence Software (MEMS AS®) to track medication-taking behaviors. Together, they provide a holistic, objective, and precise method to measure and manage adherence to solid form dose medications.
    Full story
  • Royal seal of approval for Wales-based resin manufacturer Purolite

    May 17, 2022, 15:42 PM by
    Purolite, an Ecolab company and leading manufacturer of synthetic and agarose-based resins used in the bioprocessing industry, has been awarded the prestigious Queen’s Award for Enterprise in the International Trade category.
    Full story
  • «
  • 151
  • 152
  • 153
  • 154
  • 155 (current)
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy